Pangaea Oncology (XMAD:PANG) Net Income (Continuing Operations) : €-5.51 Mil (TTM As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Pangaea Oncology Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Pangaea Oncology's Net Income (Continuing Operations) for the six months ended in Jun. 2024 was €-1.52 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2024 was €-5.51 Mil.

Pangaea Oncology Net Income (Continuing Operations) Historical Data

The historical data trend for Pangaea Oncology's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pangaea Oncology Net Income (Continuing Operations) Chart

Pangaea Oncology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income (Continuing Operations)

Get a 7-Day Free Trial

-4.84

-1.75

-0.64

-2.72

-4.79

Pangaea Oncology Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Net Income (Continuing Operations)	Get a 7-Day Free Trial															-0.93	-1.80	-0.80	-3.99	-1.52

Pangaea Oncology Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-5.51 Mil.

Pangaea Oncology (XMAD:PANG) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Pangaea Oncology Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Pangaea Oncology's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Pangaea Oncology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Pangaea Oncology SA (XMAD:PANG) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Calle Sabino Arana, 5-19, Barcelona, ESP, 08028

Website

http://www.panoncology.com

Pangaea Oncology SA is a medical services company. The company provides a wide range of services to cancer patients, as well as global pharmaceutical and biotech clients, in the fields of molecular diagnostics, clinical trials, in vitro drug profiling, dx platform validation, and biomarker discovery. The company has aggregated its operations into two segments, Clinical Care division and Diagnostic and Research and Development services division. Clinical Care division delivers medical oncology services and related activities. Diagnostic and Research and Development services division provides diagnostic and in-vitro services.

Pangaea Oncology Headlines

No Headlines